Hypolipidemic activity of Semecarpus anacardium in Streptozotocin induced diabetic rats

Endocrine

Volumn 38, Issue 1, 2010, Pages 11-17

  Jaya, Aseervatham ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Hypolipidemic; Lipid metabolizing enzymes; Lipid profile; Semecarpus anacardium

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; PHOSPHOLIPID; SEMECARPUS ANACARDIUM EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG RESPONSE; ENZYME ASSAY; HYPOLIPEMIA; KIDNEY; LIPID METABOLISM; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEMECARPUS; STREPTOZOCIN DIABETES; WISTAR RAT;

EID: 77955339857     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9360-2     Document Type: Article

References (46)

1. MR Taskinen 2002 Diabetic dyslipidemia Atheroscler. Suppl. 3 47 51 10.1016/S1567-5688(01)00006-X 1:CAS:528:DC%2BD38XktVKltLk%3D 12044586 (Pubitemid 38234478)
2. RS Gray DC Robbins W Wang JL Yeh RR Fabsitz LD Cowan TK Welty ET Lee RM Krauss BV Howard 1997 Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study Arterioscler. Thromb. Vasc. Biol. 17 2713 2720 1:STN:280:DyaK1c%2FntlOisA%3D%3D 9409247
3. MN Saraf RB Ghooi BK Patwardhan 1989 Studies on the mechanism of action of Semecarpus anacardium in rheumatoid arthritis J. Ethnopharmacol. 25 159 164 10.1016/0378-8741(89)90017-2 1:STN:280:DyaL1Mzht1OhtA%3D%3D 2747250 (Pubitemid 19095922)
4. K.M. Nadkarni, Indian Materia Medica, Vol. I (Popular Prakashan, Bombay, 1976), p. 1119
5. SSN Murthy 1992 New bioflavonoid from Semecarpus anacardium Linn Clin. Acta Turc. 20 33 37 1:CAS:528:DyaK3sXht1Sqsbk%3D
6. T Vijayalakshmi V Muthulakshmi P Sachdanandam 1997 Effect of milk extract of Semecarpus anacardium nuts on glycohydrolases and lysosomal stability in adjuvant arthritis in rats J. Ethnopharmacol. 58 1 8 10.1016/S0378-8741(97) 00074-3 1:CAS:528:DyaK2sXmtleisLk%3D 9323998 (Pubitemid 27406180)
7. AK Sahoo N Narayanan S Sahana SS Rajanb PK Mukherjee 2008 In vitro antioxidant potential of Semecarpus anacardium L. Pharmacologyonline 3 327 335
8. SG Aravind R Arimboor M Rangan N Soumya C Madhavan C Arumughan 2008 Semi-preparative HPLC preparation and HPTLC quantification of tetrahydroamentoflavone as marker in Semecarpus anacardium and its polyherbal formulations J. Pharm. Biomed. Anal. 48 808 813 10.1016/j.jpba.2008.08.008 1:CAS:528:DC%2BD1cXht1ymsL%2FO 18823732
9. YG Shin GA Cordell Y Dong JM Pezzuto AVN Appa Rao M Ramesh B Ravi Kumar M Radhakishan 1999 Rapid identification of cytotoxic alkenyl catechols in Semecarpus anacardium using bioassay-linked high performance liquid chromatography-electrospray/mass spectrometric analysis Phytochem. Anal. 10 208 212 10.1002/(SICI)1099-1565(199907/08)10:4<208::AID-PCA457>3.0.CO;2-9 1:CAS:528:DyaK1MXksFKrsrk%3D (Pubitemid 29346950)
10. PK Raveedran Nair SJ Melnick SF Wnuk M Rapp E Escalon C Ramachandran 2009 Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium J. Ethnopharmacol. 122 450 456 10.1016/j.jep.2009.02.001
11. B Premalatha P Sachdanandam 1999 Semecarpus anacardium L. Nut extract administration induces the in vivo antioxidant defence system in aflatoxin B1 mediated hepatocellular carcinoma J. Ethnopharmacol. 6 131 139 10.1016/S0378-8741(99)00029-X (Pubitemid 29307911)
12. VR Ramprasath P Shanthi P Sachdanandam 2005 Evaluation of antioxidant effect of Semecarpus anacardium Linn nut extract on the components of immune system in adjuvant arthritis Vasc. Pharmacol. 42 179 186 10.1016/j.vph.2005.02. 001 1:CAS:528:DC%2BD2MXivFyrurs%3D (Pubitemid 40463656)
13. B Arul R Kothai AJ Christina 2004 Hypoglycemic and antihyperglycemic effect of Semecarpus anacardium Linn in normal and streptozotocin-induced diabetic rats Methods Find. Exp. Clin. Pharmacol. 26 759 762 10.1358/mf.2004.26.10.872556 1:STN:280:DC%2BD2M%2FksVWiuw%3D%3D 15672117 (Pubitemid 40193971)
14. C Selvam SM Jachak 2004 A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium J. Ethnopharmacol. 95 209 212 10.1016/j.jep.2004.07.026 1:CAS:528:DC%2BD2cXovFagtrk%3D 15507338 (Pubitemid 39422672)
15. Formulary of Siddha Medicine, 2nd edn. (Indian Medicine Practitioners Co-operative Pharmacy and Stores Ltd., Madras, India, 1972), p. 197
16. DE Wilson MJ Spiger 1973 A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation J. Lab. Clin. Med. 82 473 482 1:CAS:528:DyaE3sXlt1egsL8%3D 4353880
17. AC Parekh DH Jung 1970 Cholesterol determination with ferric chloride-uranyl acetate and sulphuric acid ferrous sulphate reagents Anal. Biochem. 42 1423 1427 1:CAS:528:DyaE3cXlt1Olt7s%3D
18. J Folch M Lees GH Sloane Stanley 1957 A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 497 509 1:STN:280:DyaG2s%2FnsFCjtw%3D%3D 13428781
19. G Rouser S Fkeischer A Yamamoto 1970 Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 494 496 10.1007/BF02531316 1:CAS:528:DyaE3cXksFarurY%3D 5483450
20. E.W. Rice, Triglycerides in Serum, in Standard Methods of Clinical Chemistry, 6th edn., ed. by P. Roderick, C.H. Mcdonald (Academic Press, New York, 1970), pp. 215-222
21. WT Hron LA Menahan 1981 A sensitive method for the determination of free fatty acids in plasma J. Lipid Res. 22 377 381 1:CAS:528:DyaL3MXhslSntbo%3D 7240964
22. M Bier 1955 Enzymes of lipid metabolism. Lipases and esterases Meth. Enzymol. 1 631 638
23. A Schmidt 1974 Measurement of lipoprotein lipase and hepatic triglyceride lipase I human posttheparin plasma Meth. Enzymol. 72 325 337
24. A. Legraud, R.J. Guillansseav, J. Land, Method colorimetric simole determination del'activit., de la lecithin cholesterol acyl transferase (LCAT) Plasmatique Interest on diabeteologic, in Biologic Prospective, ed. by G. Siest, M.M. Glateau, et al. (Masson, Paris, 1979), pp. 368-371
25. HV Kothari BF Miller D Kritchevsky 1973 Aortic cholesterol esterase characteristics of normal rat and rabbit enzymes Biochem. Biophys. Acta 296 446 454 1:CAS:528:DyaE3sXktVWrsb4%3D 4688442
26. K Dahl-Jorgensen JR Larsen KF Hanssen 2005 Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment Diabetologia 8 1445 1453 10.1007/s00125-005-1832-1 (Pubitemid 41175493)
27. SS Soedamah-Muthu JH Fuller HE Mulnier VS Raleigh RA Lawrenson HM Colhoun 2006 High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database Diabetes Care 29 798 804 10.2337/diacare.29.04.06.dc05-1433 16567818
28. K Avramoglu W Qiu K Adeli 2003 Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion Front. Biosci. 8 d464 d476 10.2741/1022 1:CAS:528:DC%2BD3sXhsVejsLs%3D 12456312
29. DM Maahs AK Maniatis K Nadeau RP Wadwa K McFann GJ Klingensmith 2005 Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus J. Pediatr. 147 544 546 10.1016/j.jpeds.2005.04.068 1:CAS:528:DC%2BD2MXhtFShs7nO 16227045 (Pubitemid 41446553)
30. L Yu J Li-Hawkins RE Hammer KE Berge JD Horton JC Cohen HH Hobbs 2002 Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol J. Clin. Invest. 110 671 680 1:CAS:528:DC%2BD38Xmslyitrc%3D 12208868
31. R Stocker JF Keaney Jr 2004 Role of oxidative modifications in Atherosclerosis Physiol. Rev. 84 1381 1478 10.1152/physrev.00047.2003 1:CAS:528:DC%2BD2cXovVyltbo%3D 15383655 (Pubitemid 39302636)
32. J Chen JL Mehta N Haider X Zhang J Narula D Li 2004 Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells Circ. Res. 94 370 376 10.1161/01.RES.0000113782.07824.BE 1:CAS:528: DC%2BD2cXhtFWksr0%3D 14684629 (Pubitemid 38240729)
33. CV de Whalley SM Rankin JR Hoult W Jessup GM Wilkins J Collard DS Leake 1990 Modification of low-density lipoproteins by flavonoids Biochem. Soc. Trans. 18 1172 1173 2088842
34. A Sharma R Mathur VP Dixit 1995 Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits Indian J. Exp. Biol. 3 444 448
35. N Sambandam MA Abrahani S Craig O Al-Atar E Jeon B Rodrigues 2000 Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts Am. J. Physiol. Heart Circ. Physiol. 278 H1874 H1882 1:CAS:528: DC%2BD3cXks1ynu78%3D 10843884
36. WT Garvey S Kwon D Zheng S Shaughnessy P Wallace A Hutto K Pugh AJ Jenkins RL Klein Y Liao 2003 Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 52 453 462 10.2337/diabetes.52.2.453 1:CAS:528:DC%2BD3sXhtFansLw%3D 12540621 (Pubitemid 36173203)
37. CC Hedrick SR Thorpe MX Fu CM Harper J Yoo SM Kim H Wong AL Peters 2000 Glycation impairs high-density lipoprotein function Diabetologia 43 312 320 10.1007/s001250050049 1:CAS:528:DC%2BD3cXhsFylur8%3D 10768092
38. I Ahmed MS Lakhani M Gillett A John H Raza 2001 Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats Diabetes Res. Clin. Pract. 51 155 161 10.1016/S0168-8227(00)00224-2 1:STN:280:DC%2BD3M7nt1OjtQ%3D%3D 11269887 (Pubitemid 32223909)
39. JD McGarry 2002 Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 51 1 7 18 10.2337/diabetes.51.1.7 1:CAS:528:DC%2BD38Xlt1ejsQ%3D%3D 11756317
40. P Iozzo AK Turpeinen T Takala V Oikonen J Bergman T Grönroos E Ferrannini P Nuutila J Knuuti 2004 Defective liver disposal of free fatty acids in patients with impaired glucose tolerance J. Clin. Endocrinol. Metab. 89 3496 3502 10.1210/jc.2003-031142 1:CAS:528:DC%2BD2cXlslegt7k%3D 15240637 (Pubitemid 38951926)
41. D Pighin L Karabatas C Pastorale E Dascal C Carbone A Chicco YB Lombardo JC Basabe 2005 Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin J. Appl. Physiol. 8 1064 1069
42. G Shepherd MC Cam N Sambandam MA Abrahani B Rodrigues 1998 Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats Hypertension 31 878 884 1:CAS:528:DyaK1cXhsFektLo%3D 9495276
43. A Kiziltunc F Akçay F Polat S Kuşkay YN Sahin 1997 Reduced lecithin: cholesterol acyltransferase (LCAT) and Na+, K+, ATPase activity in diabetic patients Clin. Biochem. 30 2 177 182 10.1016/S0009-9120(96)00156-7 1:CAS:528:DyaK2sXjtVKmt74%3D 9127701 (Pubitemid 27180932)
44. E Nobecourt MJ Davies BE Brown LK Curtiss DJ Bonnet F Charlton AS Januszewski AJ Jenkins PJ Barter KA Rye 2007 The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin: cholesterol acyltransferase Diabetologia 50 643 653 10.1007/s00125-006-0574-z 1:CAS:528:DC%2BD2sXhtlKis70%3D 17216278 (Pubitemid 46215509)
45. YB Tripathi RS Pandey 2004 Semecarpus anacardium L, nuts inhibit lipopolysaccharide induced NO production in rat macrophages along with its hypolipidemic property Indian J. Exp. Biol. 42 432 436 1:STN:280: DC%2BD2c7pt1OjtQ%3D%3D 15088696
46. H El Hajji E Nkhili V Tomao O Dangles 2006 Interactions of quercetin with iron and copper ions: complexation and autoxidation Free Radic. Res. 40 303 320 10.1080/10715760500484351 1:CAS:528:DC%2BD28XhsVSlt7k%3D 16484047 (Pubitemid 43245446)